CalciMedica, Inc. (CALC) Stock

Healthcare · Biotechnology · Member of Other US Stocks

CalciMedica, Inc. (CALC) closed at USD 1.08 on 2026-10-15, a change of -92.7 % over the past year, with a market capitalization of USD 7.1M.

CalciMedica, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

CalciMedica, Inc. key figures

Previous close

USD 1.08 (2026-10-15)

1-year change

-92.7 %

Market cap

USD 7.1M

Enterprise value

USD -2.32M

P/E ratio (trailing)

-0.15

P/E ratio (forward)

-0.64

EPS (trailing)

-6.85

EPS (forward)

-1.63

PEG ratio

n/a

Price to book

1.16

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

1.04

Employees

15

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About CalciMedica, Inc.

CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for CalciMedica, Inc. and compare it with other stocks.